Moreover, in a NASH mouse model, hepatocyte-specific TGFB receptor type II (Tgfbr2) deficiency reduced hepatic steatosis, inflammation, hepatic stellate cell activation, and collagen deposition17. Here, TGFBR2 is linked to metabolic dysfunction-associated steatohepatitis.